Valo Health
Integrates human data and machine learning to accelerate therapeutic discovery.
What they do
Valo Health developed the Opal Platform, an end to end proprietary operating system designed to streamline drug discovery and development. By using human centric data and machine learning, they help drug developers minimize risk and speed up clinical trial timelines.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- AI drug discovery
- Product type
- Platform software
- Stage
- Series C+
- Headquarters
- Boston, United States
- Region
- North America
- Founded
- 2019
- Total funding
- $439M raised
Notable investors: Koch Disruptive Technologies, Flagship Pioneering, Fidelity Management, PSP Investments.